These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38497452)

  • 1. Impaired Relaxation in Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Pathogenic
    Wang R; Hasegawa M; Suginobe H; Yoshihara C; Ishii Y; Ueyama A; Ueda K; Hashimoto K; Hirose M; Ishii R; Narita J; Watanabe T; Kawamura T; Taira M; Ueno T; Miyagawa S; Ishida H
    J Am Heart Assoc; 2024 Mar; 13(6):e032375. PubMed ID: 38497452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
    Hasegawa M; Miki K; Kawamura T; Takei Sasozaki I; Higashiyama Y; Tsuchida M; Kashino K; Taira M; Ito E; Takeda M; Ishida H; Higo S; Sakata Y; Miyagawa S
    Dev Growth Differ; 2024 Feb; 66(2):119-132. PubMed ID: 38193576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic analysis of a child with restricted cardiomyopathy and phenylketonuria and a literature review].
    Wang F; Xiao M; Sun Q; Jia L; Lyu A; Yao X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):990-997. PubMed ID: 37532500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Whole-exome Sequencing in Phenotype Classification and Clinical Treatment of Pediatric Restrictive Cardiomyopathy.
    Ding WH; Han L; Xiao YY; Mo Y; Yang J; Wang XF; Jin M
    Chin Med J (Engl); 2017 Dec; 130(23):2823-2828. PubMed ID: 29176140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
    Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
    Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy].
    Yang SW; Chen Y; Li J; Yin J; Qin YM; Andelfinger G; Wang DW; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Apr; 41(4):304-9. PubMed ID: 23906401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
    Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical genetic testing in four highly suspected pediatric restrictive cardiomyopathy cases.
    Zheng M; Huang H; Zhu X; Ho H; Li L; Ji X
    BMC Cardiovasc Disord; 2022 May; 22(1):240. PubMed ID: 35614389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells.
    Pavlova SV; Shulgina AE; Zakian SM; Dementyeva EV
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence.
    Garbern JC; Helman A; Sereda R; Sarikhani M; Ahmed A; Escalante GO; Ogurlu R; Kim SL; Zimmerman JF; Cho A; MacQueen L; Bezzerides VJ; Parker KK; Melton DA; Lee RT
    Circulation; 2020 Jan; 141(4):285-300. PubMed ID: 31707831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery.
    Wang BZ; Nash TR; Zhang X; Rao J; Abriola L; Kim Y; Zakharov S; Kim M; Luo LJ; Morsink M; Liu B; Lock RI; Fleischer S; Tamargo MA; Bohnen M; Welch CL; Chung WK; Marx SO; Surovtseva YV; Vunjak-Novakovic G; Fine BM
    Cell Rep Med; 2023 Mar; 4(3):100976. PubMed ID: 36921598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Fibroblasts Play Pathogenic Roles in Idiopathic Restrictive Cardiomyopathy.
    Tsuru H; Ishida H; Narita J; Ishii R; Suginobe H; Ishii Y; Wang R; Kogaki S; Taira M; Ueno T; Miyashita Y; Kioka H; Asano Y; Sawa Y; Ozono K
    Circ J; 2021 Apr; 85(5):677-686. PubMed ID: 33583869
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
    Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.
    Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM
    J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
    Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
    Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
    Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
    J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium desensitizer catechin reverses diastolic dysfunction in mice with restrictive cardiomyopathy.
    Zhang L; Nan C; Chen Y; Tian J; Jean-Charles PY; Getfield C; Wang X; Huang X
    Arch Biochem Biophys; 2015 May; 573():69-76. PubMed ID: 25813360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.
    Mogensen J; Kubo T; Duque M; Uribe W; Shaw A; Murphy R; Gimeno JR; Elliott P; McKenna WJ
    J Clin Invest; 2003 Jan; 111(2):209-16. PubMed ID: 12531876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.